Will Blucora Inc(NASDAQ:BCOR) and NuVasive, Inc.(NASDAQ:NUVA)Become Industry Leaders?


Atlanta, GA – Scibility Media – 11/19/2014.

This article discusses two companies: Blucora Inc(NASDAQ:BCOR) and NuVasive, Inc.(NASDAQ:NUVA)

Blucora Inc(NASDAQ:BCOR) traded for as little as $13.81 yesterday, a new 52 week low for the company that once traded for as much as $29.99. The Washington-based company operates a portfolio of businesses in the United States and internationally, including Dogpile.com and WebCrawler.com.

The company reported its third quarter financial results on Nov. 5th, 2014. The figures included a 7% year-over-year decrease in revenue, a 36% decrease in adjusted EBITDA, and a 50% decrease in non-GAAP net income. However, Blucora’s net loss, while significant, did improve from the $6.5 million figure recorded during third quarter 2013 to $2.2 million.

The company, which has a three month average volume of 0.73 million, has a market capitalization of $582.22 million and 41 million tradeable shares.

Starved For Yield? Find New Investment Opportunities.

NuVasive, Inc.(NASDAQ:NUVA)is a California-based medical device company that develops and markets minimally disruptive surgical products and procedurally integrated spinal solutions. The company sells its products through independent sales agencies and distributors to surgeons and hospitals.

The company recently attended the 29th North American Spine Society Annual Meeting, which was held in San Francisco, CA between the dates of Nov. 12th and 15th.

The stock has traded within a range of $30.96 to $45.63 over the past 52 weeks, yet finished yesterday’s trading at a closing price of $43.97. These figures suggest that NuVasive is a safe, strong investment option. The company has a market capitalization of $2.07 billion and 47.04 million tradeable shares.

Tired Of Third-Party Bias? Us Too! Talk To NuVasive, Inc Directly!

About EquiPress.com

EquiPress.com is a non-advertisement based network (currently in limited release) designed for investors to discover and communicate with publicly traded companies in real-time.

Sign-up for free now to experience the full benefits of EquiPress pre-launch.

Discover and communicate with companies you would otherwise never have seen based on your interests, company news, personalized news feeds, and one-on-one communications with no middle-men nor advertisements. Read our no advertisements pledge.

Can’t find your company on EquiPress? Send us an email to support@equipress.com and we will contact them for you.

Interested in a one month free trial? Get access to our private investor network, real-time news distribution, automatic disclaimers, corporate analytics, verified public profile, and industry-wide marketing of your corporate news.

Disclosure: EquiPress is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. EquiPress does not hold any equity or financial interest in any publicly traded company. EquiPress provides a uniform subscription based service to all publicly traded companies on a monthly basis at a rate of $495 to provide investor awareness. EquiPress receives only cash compensation from clients. Despite the relationship, EquiPress maintains a neutral stance (nonbiased) on any investment related opinions and exists solely for the purpose of allowing investors to communicate with the publicly traded companies in an effort to establish for themselves investment considerations. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor. Please visit www.equipress.com for complete risks and disclosures.


Leave A Reply